Molecular dynamics simulation-guided drug sensitivity prediction for lung cancer with rare EGFR mutations

Next generation sequencing (NGS)-based tumor profiling identified an overwhelming number of uncharacterized somatic mutations, also known as variants of unknown significance (VUS). The therapeutic significance of mutations outside mutational hotspots, consisting of >50 types, in nonsmall cell lun...

Full description

Saved in:

Bibliographic Details
Published in:	Proceedings of the National Academy of Sciences - PNAS Vol. 116; no. 20; p. 10025
Main Authors:	Ikemura, Shinnosuke, Yasuda, Hiroyuki, Matsumoto, Shingo, Kamada, Mayumi, Hamamoto, Junko, Masuzawa, Keita, Kobayashi, Keigo, Manabe, Tadashi, Arai, Daisuke, Nakachi, Ichiro, Kawada, Ichiro, Ishioka, Kota, Nakamura, Morio, Namkoong, Ho, Naoki, Katsuhiko, Ono, Fumie, Araki, Mitsugu, Kanada, Ryo, Ma, Biao, Hayashi, Yuichiro, Mimaki, Sachiyo, Yoh, Kiyotaka, Kobayashi, Susumu S, Kohno, Takashi, Okuno, Yasushi, Goto, Koichi, Tsuchihara, Katsuya, Soejima, Kenzo
Format:	Journal Article
Language:	English
Published:	United States 14.05.2019
Subjects:	Acrylamides - therapeutic use Adenocarcinoma - drug therapy Aniline Compounds - therapeutic use Carcinoma, Non-Small-Cell Lung - genetics Genes, erbB-1 Humans Lung Neoplasms - drug therapy Lung Neoplasms - genetics Middle Aged Molecular Dynamics Simulation Mutation Pharmacogenomic Testing Prospective Studies Protein-Tyrosine Kinases - antagonists & inhibitors rare EGFR mutation mutation diversity in silico prediction model nonsmall cell lung cancer osimertinib
ISSN:	1091-6490, 1091-6490
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!